Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors

AIDS

Volumn 20, Issue 5, 2006, Pages 775-778

  Gay, Cynthia L ^a   Napravnik, Sonia ^a   Eron Jr , Joseph J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CELL COUNT; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MULTIVARIATE ANALYSIS; NONHUMAN; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; SEX RATIO; UNITED STATES;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOSUPPRESSION; LOGISTIC MODELS; MALE; NORTH CAROLINA; PATIENT SELECTION; RISK FACTORS; RNA, VIRAL; SEX FACTORS; TIME FACTORS;

EID: 33745101086     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000216380.30055.4a     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention. Late versus early testing of HIV - 16 sites, United States, 2000-2003. Morb Mortal Wkly Rep 2003; 52:581-586.
2. Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, O'Shaughnessy MV, Montaner JS. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286:2568-2577.
3. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360:119-129.
4. Gupta SB, Gilbert RL, Brady AR, Livingstone SJ, Evans BG. CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990-1998. CD4 Surveillance Scheme Advisory Group. AIDS 2000; 14:853-861.
5. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS 2001; 15:77-85.
6. Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002; 16:1945-1951.
7. Klein D, Hurley LB, Merrill D, Quesenberry CP Jr. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr 2003; 32:143-152.
8. Girardi E, Aloisi M, Arici C, Pezzotti P, Serraino D, Balzano R, et al. Delayed presentation and late testing for hiv: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004; 36:951-959.
9. Manavi K, McMillan A, Ogilvie M, Scott G. Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS 2004; 15:811-814.
10. Hocking JS, Rodger AJ, Rhodes DG, Crofts N. Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis - characteristics of individuals. Int J STD AIDS 2000; 11:503-508.
11. Dybul M, Bolan R, Condoluci D, Cox-Iyamu R, Redfield R, Hallahan CW, et al. Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J Infect Dis 2002; 185:1818-1821.
12. Centers for Disease Control and Prevention. First 500,000 AIDS cases - United States, 1995. MMWR Morb Mortal Wkly Rep 1995; 44:849-853.
13. Centers for Disease Control and Prevention. Update: AIDS - United States, 2000. MMWR Morb Mortal Wkly Rep 2002; 51:592-595.
14. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: Department of Health and Human Services; 2004.
15. US Census Bureau. Census 2000 basics. Available at http://www.census.gov. Accessed: 31 January 2005.
16. Samet JH, Retondo MJ, Freedberg KA, Stein MD, Heeren T, Libman H. Factors associated with initiation of primary medical care for HIV-infected persons. Am J Med 1994; 97:347-353.
17. Katz MH, Bindman AB, Keane D, Chan AK. CD4 lymphocyte count as an indicator of delay in seeking human immunodeficiency virus-related treatment. Arch Intern Med 1992; 152:1501-1504.
18. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. Atlanta, GA: CDC; 2001. p. 13.
19. Wortley PM, Chu SY, Diaz T, Ward JW, Doyle B, Davidson AJ, et al. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? AIDS 1995; 9:487-492.
20. Whetten K, Reif SS, Napravnik S, Swartz MS, Thielman NM, Eron JJ Jr et al. Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast. South Med J 2005; 98:9-14.
21. Galvan FH, Burnam MA, Bing EG. Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. J Psychoactive Drugs 2003; 35 (Suppl. 1):153-160.
22. Lam NS, Liu KB. Spread of AIDS in rural America, 1982-1990. J Acquir Immune Defic Syndr 1994; 7:485-490.
23. Berry DE. The emerging epidemiology of rural AIDS. J Rural Health 1993; 9:293-304.
24. Holmes R, Fawal H, Moon TD, Cheeks J, Coleman J, Woernle C, Vermund SH. Acquired immunodeficiency syndrome in Alabama: special concerns for black women. South Med J 1997; 90:697-701.
25. Centers for Disease Control and Prevention. Risks for HIV infection among persons residing in rural areas and small cities - selected sites, Southern United States, 1995-1996. Morb Mortal Wkly Rep 1998; 47:974-978.
26. Crosby RA, Yarber WL, DiClemente RJ, Wingood GM, Meyerson B. HIV-associated histories, perceptions, and practices among low-income African American women: does rural residence matter? Am J Public Health 2002; 92:655-659.
27. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-954.
28. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
29. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409.